Diarrhea-associated hemolytic uremic syndrome (D+HUS) is a common thrombotic microangiopathy during childhood and early identification of parameters predicting poor outcome could enable timely intervention. This study aims to establish the accuracy of BUN-to-serum creatinine ratio at admission, in addition to other parameters in predicting the clinical course and outcome. Records were searched for children between 1 January 2008 and 1 January 2015 admitted with D+HUS. A complicated course was defined as developing one or more of the following: neurological dysfunction, pancreatitis, cardiac or pulmonary involvement, hemodynamic instability, and hematologic complications while poor outcome was defined by death or development of chronic kidney disease. Thirty-four children were included from which 11 with a complicated disease course/poor outcome. Risk of a complicated course/poor outcome was strongly associated with oliguria (p = 0.000006) and hypertension (p = 0.00003) at presentation. In addition, higher serum creatinine (p = 0.000006) and sLDH (p = 0.02) with lower BUN-to-serum creatinine ratio (p = 0.000007) were significantly associated with development of complications. A BUN-to-sCreatinine ratio ≤40 at admission was a sensitive and highly specific predictor of a complicated disease course/poor outcome.
Conclusion: A BUN-to-serum Creatinine ratio can accurately identify children with D+HUS at risk for a complicated course and poor outcome.
What is Known:
• Oliguria is a predictor of poor long-term outcome in D+HUS
What is New:
• BUN-to-serum Creatinine ratio at admission is an entirely novel and accurate predictor of poor outcome and complicated clinical outcome in D+HUS
• Early detection of the high risk group in D+HUS enabling early treatment and adequate monitoring
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Area under the curve
Blood urea nitrogen
Chronic kidney disease
Estimated creatinine clearance
Enterohemorrhagic E. coli
Hemolytic uremic syndrome
Receiver operating characteristic
Serum lactate dehydrogenase
Shiga Toxin producing Enterohemorrhagic E.coli
Agrawal M, Swartz R (2000) Acute renal failure. Am Fam Physician 61:2077–2088
Ardissino G, Daccò V, Testa S, Civitillo CF, Tel F, Possenti I et al (2015) Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome. Pediatr Nephrol 30(2):345–352. doi:10.1007/s00467-014-
Balestracci A, Martin SM, Toledo I (2015) Hemoconcentration in hemolytic uremic syndrome: time to review the standard case definition? Pediatr Nephrol 30(2):361. doi:10.1007/s00467-014-2984-3
Gould LH, Demma L, Jones TF, Vugia DJ, Smith K, Shiferaw B et al (2009) Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000–2006. Clin Infect Dis 49(10):1480–1485. doi:10.1086/644621
Karpman D (2012) Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed. Nephrol Dial Transplant 27(10):3669–3674. doi:10.1093/ndt/gfs456
Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J et al (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. Br Med J 345:e4565
Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J et al (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5(7):1218–1228. doi:10.2215/CJN.08921209
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576
Nguyen Y, Sperandio V (2012) Enterohemorrhagic E. coli (EHEC) pathogenis. Front Cell Infect Microbiol 2:90. doi:10.3389/fcimb.2012.00090
Oakes RS, Kirkham JK, Nelson RD, Siegler RL (2008) Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 23(8):1303–1308. doi:10.1007/s00467-008-0799-9 Erratum in: Pediatr Nephrol. 23(11):2105
Perez N, Spizzirri F, Rahman R, Suarez A, Larrubia C, Lasarte P (1998) Steroids in the hemolytic uremic syndrome. Pediatr Nephrol 12(2):101–104
Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23(10):1749–1760. doi:10.1007/s00467-008-0935-6
Tserenpuntsag B, Chang H, Perry F, Smith PF, Dale L, Morse DL (2005) Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infect Dis 11(12):1955–1957. doi:10.3201/eid1112.050607
Valles PG, Pesle S, Piovano L, Davila E, Peralta M, Principi I, Lo Giudice P (2005) Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina (B Aires) 65(5):395–401
We would like to thank and acknowledge Ghent University for their ongoing support and cooperation, enabling this study to be performed.
Dr. Werner Keenswijk wrote the initial draft of this paper and all authors were involved in gathering data, paper revision, analysis and final approval of this paper.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflict of interest.
No informed consent was obtained do to the retrospective nature of this study but ethical approval was obtained and patient anonymity was strictly protected.
No funding was provided to perform this study.
Communicated by Mario Bianchetti
About this article
Cite this article
Keenswijk, W., Vanmassenhove, J., Raes, A. et al. Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study. Eur J Pediatr 176, 355–360 (2017). https://doi.org/10.1007/s00431-016-2846-z
- Hemolytic uremic syndrome
- BUN-to-sCreatinine ratio
- Complicated course
- Poor outcome
- Thrombothic micro-angiopathy (TMA)